Patents by Inventor Aiman Shalabi

Aiman Shalabi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR PD-L1 NEGATIVE TUMORS
    Publication number: 20160060344
    Abstract: The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and tremelimumab in a subject identified as having a PD-L1 negative tumor.
    Type: Application
    Filed: August 28, 2015
    Publication date: March 3, 2016
    Inventors: Rajesh Narwal, Marlon C. Rebelatto, Keith Steele, Paul Robbins, Ross Anthony Stewart, John A. Blake-Haskins, Joyson J. Karakunnel, Ramy Ibrahim, Aiman Shalabi, Alessandra Di Pietro, Li Shi, Shengyan Hong, Paul Stockman, Marc Ballas, Mohammed M. Dar
  • ANTAGONISTS OF PDL-1 AND PD-1 FOR THE TREATMENT OF HPV-NEGATIVE CANCERS
    Publication number: 20160031990
    Abstract: Provided herein are methods of treating HPV-negative tumors comprising administering an effective amount of an antagonist of the PDL-1/PD-1 interaction (e.g., an anti-PDL-1 or anti-PD-1 antibody antigen binding fragment thereof).
    Type: Application
    Filed: May 28, 2015
    Publication date: February 4, 2016
    Inventors: Keith STEELE, Marlon C. Rebelatto, John Andrew Blake-Haskins, Paul B. Robbins, James R. Vasselli, Ross A. Stewart, Ramy Ibrahim, Aiman Shalabi